価格表
在庫・価格 : 2025年04月26日 07時29分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-CRISPR/Cas9, Mouse-Mono(7A9) データシート |
A-9000-100 |
EPGエピジェンテックグループ Epigentek Group Inc. |
100 μg | ¥84,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年04月26日 07時29分 現在
使用文献
- No.: 1
-
文献情報:
Fuller KK et al. Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus. Eukaryotic Cell 2015 Nov;14(11):1073-80
Fuller KK et al
2015/01/01
-
備考:
-
参照:
- No.: 2
-
文献情報:
Wang D et al. Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. Hum. Gene Ther. 2015 Jul;26(7):432-42
Wang D et al
2015/01/01
-
備考:
-
参照:
- No.: 3
-
文献情報:
Chew WL et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat. Methods 2016 Oct;13(10):868-74
Chew WL et al
2016/01/01
-
備考:
-
参照:
- No.: 4
-
文献情報:
Li S et al. One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes. Mol Ther Nucleic Acids 2017 Sep;8:64-76
Li S et al
2017/01/01
-
備考:
-
参照:
- No.: 5
-
文献情報:
Behler J et al. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system. Nat Microbiol 2018 03;3(3):367-377
Behler J et al
2018/01/01
-
備考:
-
参照:
- No.: 6
-
文献情報:
Hu J et al. A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model. Mol Ther Methods Clin Dev 2018 Jun;9:203-210
Hu J et al
2018/01/01
-
備考:
-
参照:
- No.: 7
-
文献情報:
Ophinni Y et al. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures. Sci Rep 2018 May;8(1):7784
Ophinni Y et al
2018/01/01
-
備考:
-
参照:
- No.: 8
-
文献情報:
Chen H et al. Efficient Genome Editing of <i>Magnetospirillum magneticum</i> AMB-1 by CRISPR-Cas9 System for Analyzing Magnetotactic Behavior. Front Microbiol 2018;9:1569
Chen H et al
2018/01/01
-
備考:
-
参照:
- No.: 9
-
文献情報:
Yarrington RM et al. Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo. Proc. Natl. Acad. Sci. U.S.A. 2018 09;115(38):9351-9358
Yarrington RM et al
2018/01/01
-
備考:
-
参照:
- No.: 10
-
文献情報:
Rossidis AC et al. In utero CRISPR-mediated therapeutic editing of metabolic genes. Nat. Med. 2018 10;24(10):1513-1518
Rossidis AC et al
2018/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
McInally SG et al. Robust and stable transcriptional repression in Giardia using CRISPRi. Mol Biol Cell 2019 01;30(1):119-130
McInally SG et al
2019/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Ajina R et al. SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice. Oncoimmunology ;8(5):e1577127
Ajina R et al
-
備考:
-
参照:
- No.: 13
-
文献情報:
Moran JD et al. SOX4 regulates invasion of bladder cancer cells via repression of WNT5a. Int. J. Oncol. 2019 Aug;55(2):359-370
Moran JD et al
2019/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Taghbalout A et al. Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways. Nat Commun 2019 09;10(1):4296
Taghbalout A et al
2019/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Jiang T et al. Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope. Nat Commun 2020 04;11(1):1979
Jiang T et al
2020/01/01
-
備考:
-
参照:
- No.: 16
-
文献情報:
Yang D et al. The microRNA/TET3/REST axis is required for olfactory globose basal cell proliferation and male behavior. EMBO Rep 2020 09;21(9):e49431
Yang D et al
2020/01/01
-
備考:
-
参照:
- No.: 17
-
文献情報:
Glykofridis IE et al. Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells. Elife 2021 Jan;10
Glykofridis IE et al
2021/01/01
-
備考:
-
参照:
- No.: 18
-
文献情報:
Aparicio Prat E. et. al.Roadmap for the use of Base Editors to Decipher Drug Mechanism of Action., Research Square.,
-
備考:
-
参照: